However they could not functionally demonstrate a role for ATM in restraining ErbB2-dependent tumorigenesis as ATM-null mice succumb to T cell lymphomas and other diseases rapidly, earlier than mammary tumor development in response to active ErbB2 expression, precluding the in vivo functional experiments [45]. This evidence concerns the gene ATM and T-cell non-Hodgkin lymphoma.